CARL J JOHNSON Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CARL J JOHNSON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CARL J JOHNSON. CARL J JOHNSON is a CEO & President in MATRIXX INITIATIVES INC ($MTXX) and a President & CEO in MATRIXX INITIATIVES INC ($MTXX) and a Presidient & CEO in MATRIXX INITIATIVES INC ($MTXX) and a Director in SCOLR Pharma, Inc. ($SCLL.OB) and a Director in Prestige Brands Holdings, Inc. ($PBH) and a President & CEO in Entia Biosciences, Inc. ($GMKG) and a President and CEO in Entia Biosciences, Inc. ($GMKG).
Address: SCOLR PHARMA, INC. 19204 NORTH CREEK PARKWAY, SUITE 100 BOTHELL 98011 WA
Companies in which CARL J JOHNSON is an Insider
Entia Biosciences, Inc.
Industry: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
Position of CARL J JOHNSON: President and CEO, President & CEO
Holdings: 300,000 shares
Latest Transaction: Feb 16 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MATRIXX INITIATIVES INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CARL J JOHNSON: Presidient & CEO, President & CEO, CEO & President
Holdings: 107,911 shares
Latest Transaction: May 12 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Prestige Consumer Healthcare Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CARL J JOHNSON: Director
Holdings: 14,598 shares
Current Value: $811,503
Latest Transaction: Aug 01 2018
$PBH Market Capitalization: $2.94B
$PBH Previous Close: $55.59
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SCOLR Pharma, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of CARL J JOHNSON: Director
Holdings: 0 shares
Latest Transaction: Jun 13 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of CARL J JOHNSON
Sentiment: All, GMKG, MTXX, PBH, SCLL.OB
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 01 2018 | PBH | Prestige Brands Ho ... | JOHNSON CARL J | Director | Grant | A | 0.00 | 3,779 | 0 | 14,598 | 10.8 K to 14.6 K (+34.93 %) |
| Aug 03 2017 | PBH | Prestige Brands Ho ... | JOHNSON CARL J | Director | Grant | A | 0.00 | 2,564 | 0 | 10,819 | 8.3 K to 10.8 K (+31.06 %) |
| Feb 16 2017 | GMKG | Entia Biosciences, ... | JOHNSON CARL J | President and CEO | Grant | A | 0.00 | 250,000 | 0 | 850,000 | 600 K to 850 K (+41.67 %) |
| Feb 16 2017 | GMKG | Entia Biosciences, ... | JOHNSON CARL J | President and CEO | Grant | A | 0.00 | 300,000 | 0 | 600,000 | 300 K to 600 K (+100.00 %) |
| Feb 16 2017 | GMKG | Entia Biosciences, ... | JOHNSON CARL J | President and CEO | Grant | A | 0.00 | 300,000 | 0 | 300,000 | 0 to 300 K |
| Aug 04 2016 | PBH | Prestige Brands Ho ... | JOHNSON CARL J | Director | Grant | A | 0.00 | 1,896 | 0 | 8,255 | 6.4 K to 8.3 K (+29.82 %) |
| May 24 2016 | GMKG | Entia Biosciences, ... | JOHNSON CARL J | President & CEO | Option Exercise | P | 0.13 | 25,000 | 3,125 | 25,000 |